Pseudotumor cerebri presenting as headache

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Pseudotumor cerebri (PTC) is characterized by intracranial hypertension without ventriculomegaly, in the absence of a mass lesion or meningeal process. When there is no secondary cause, it is termed 'idiopathic intracranial hypertension'. Headache is the most common symptom of PTC, present in over 90% of patients. The headache is often disabling and nonspecific in character; thus, ophthalmoscopy is imperative for all patients being evaluated for headache. Visual loss is the major morbidity of PTC, requiring prompt diagnosis and treatment to prevent permanent deficits. Medical and surgical treatments are employed, although evidence-based treatment guidelines do not exist. This review discusses the diagnosis, differential diagnosis and management strategies for patients with PTC.

Original languageEnglish (US)
Pages (from-to)397-407
Number of pages11
JournalExpert Review of Neurotherapeutics
Volume8
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Pseudotumor Cerebri
Headache
Ophthalmoscopy
Intracranial Hypertension
Differential Diagnosis
Therapeutics
Guidelines
Morbidity

Keywords

  • Cerebrospinal fluid shunt
  • Headache disorder
  • Intracranial hypertension
  • Obesity
  • Papilledema
  • Pseudotumor cerebri
  • Secondary

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Pseudotumor cerebri presenting as headache. / Friedman, Deborah I.

In: Expert Review of Neurotherapeutics, Vol. 8, No. 3, 03.2008, p. 397-407.

Research output: Contribution to journalArticle

@article{14d3259125ea4d49846d193bf4c0e3d8,
title = "Pseudotumor cerebri presenting as headache",
abstract = "Pseudotumor cerebri (PTC) is characterized by intracranial hypertension without ventriculomegaly, in the absence of a mass lesion or meningeal process. When there is no secondary cause, it is termed 'idiopathic intracranial hypertension'. Headache is the most common symptom of PTC, present in over 90{\%} of patients. The headache is often disabling and nonspecific in character; thus, ophthalmoscopy is imperative for all patients being evaluated for headache. Visual loss is the major morbidity of PTC, requiring prompt diagnosis and treatment to prevent permanent deficits. Medical and surgical treatments are employed, although evidence-based treatment guidelines do not exist. This review discusses the diagnosis, differential diagnosis and management strategies for patients with PTC.",
keywords = "Cerebrospinal fluid shunt, Headache disorder, Intracranial hypertension, Obesity, Papilledema, Pseudotumor cerebri, Secondary",
author = "Friedman, {Deborah I}",
year = "2008",
month = "3",
doi = "10.1586/14737175.8.3.397",
language = "English (US)",
volume = "8",
pages = "397--407",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Pseudotumor cerebri presenting as headache

AU - Friedman, Deborah I

PY - 2008/3

Y1 - 2008/3

N2 - Pseudotumor cerebri (PTC) is characterized by intracranial hypertension without ventriculomegaly, in the absence of a mass lesion or meningeal process. When there is no secondary cause, it is termed 'idiopathic intracranial hypertension'. Headache is the most common symptom of PTC, present in over 90% of patients. The headache is often disabling and nonspecific in character; thus, ophthalmoscopy is imperative for all patients being evaluated for headache. Visual loss is the major morbidity of PTC, requiring prompt diagnosis and treatment to prevent permanent deficits. Medical and surgical treatments are employed, although evidence-based treatment guidelines do not exist. This review discusses the diagnosis, differential diagnosis and management strategies for patients with PTC.

AB - Pseudotumor cerebri (PTC) is characterized by intracranial hypertension without ventriculomegaly, in the absence of a mass lesion or meningeal process. When there is no secondary cause, it is termed 'idiopathic intracranial hypertension'. Headache is the most common symptom of PTC, present in over 90% of patients. The headache is often disabling and nonspecific in character; thus, ophthalmoscopy is imperative for all patients being evaluated for headache. Visual loss is the major morbidity of PTC, requiring prompt diagnosis and treatment to prevent permanent deficits. Medical and surgical treatments are employed, although evidence-based treatment guidelines do not exist. This review discusses the diagnosis, differential diagnosis and management strategies for patients with PTC.

KW - Cerebrospinal fluid shunt

KW - Headache disorder

KW - Intracranial hypertension

KW - Obesity

KW - Papilledema

KW - Pseudotumor cerebri

KW - Secondary

UR - http://www.scopus.com/inward/record.url?scp=41649104356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649104356&partnerID=8YFLogxK

U2 - 10.1586/14737175.8.3.397

DO - 10.1586/14737175.8.3.397

M3 - Article

VL - 8

SP - 397

EP - 407

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 3

ER -